---
reference_id: "PMID:28757203"
title: Biallelic Mutations in LIPT2 Cause a Mitochondrial Lipoylation Defect Associated with Severe Neonatal Encephalopathy.
authors:
- Habarou F
- Hamel Y
- Haack TB
- Feichtinger RG
- Lebigot E
- Marquardt I
- Busiah K
- Laroche C
- Madrange M
- Grisel C
- Pontoizeau C
- Eisermann M
- Boutron A
- Chrétien D
- Chadefaux-Vekemans B
- Barouki R
- Bole-Feysot C
- Nitschke P
- Goudin N
- Boddaert N
- Nemazanyy I
- Delahodde A
- Kölker S
- Rodenburg RJ
- Korenke GC
- Meitinger T
- Strom TM
- Prokisch H
- Rotig A
- Ottolenghi C
- Mayr JA
- de Lonlay P
journal: Am J Hum Genet
year: '2017'
doi: 10.1016/j.ajhg.2017.07.001
content_type: abstract_only
---

# Biallelic Mutations in LIPT2 Cause a Mitochondrial Lipoylation Defect Associated with Severe Neonatal Encephalopathy.
**Authors:** Habarou F, Hamel Y, Haack TB, Feichtinger RG, Lebigot E, Marquardt I, Busiah K, Laroche C, Madrange M, Grisel C, Pontoizeau C, Eisermann M, Boutron A, Chrétien D, Chadefaux-Vekemans B, Barouki R, Bole-Feysot C, Nitschke P, Goudin N, Boddaert N, Nemazanyy I, Delahodde A, Kölker S, Rodenburg RJ, Korenke GC, Meitinger T, Strom TM, Prokisch H, Rotig A, Ottolenghi C, Mayr JA, de Lonlay P
**Journal:** Am J Hum Genet (2017)
**DOI:** [10.1016/j.ajhg.2017.07.001](https://doi.org/10.1016/j.ajhg.2017.07.001)

## Content

1. Am J Hum Genet. 2017 Aug 3;101(2):283-290. doi: 10.1016/j.ajhg.2017.07.001.
Epub  2017 Jul 27.

Biallelic Mutations in LIPT2 Cause a Mitochondrial Lipoylation Defect Associated 
with Severe Neonatal Encephalopathy.

Habarou F(1), Hamel Y(2), Haack TB(3), Feichtinger RG(4), Lebigot E(5), 
Marquardt I(6), Busiah K(7), Laroche C(8), Madrange M(2), Grisel C(7), 
Pontoizeau C(1), Eisermann M(9), Boutron A(5), Chrétien D(10), 
Chadefaux-Vekemans B(1), Barouki R(1), Bole-Feysot C(11), Nitschke P(12), Goudin 
N(13), Boddaert N(14), Nemazanyy I(15), Delahodde A(16), Kölker S(17), Rodenburg 
RJ(18), Korenke GC(6), Meitinger T(19), Strom TM(19), Prokisch H(19), Rotig 
A(10), Ottolenghi C(1), Mayr JA(20), de Lonlay P(21).

Author information:
(1)Reference Center of Inherited Metabolic Diseases, University Paris Descartes, 
Hospital Necker Enfants Malades, APHP, 75015 Paris, France; Metabolic 
Biochemistry, University Paris Descartes, Hospital Necker Enfants Malades, 75015 
Paris, France.
(2)Reference Center of Inherited Metabolic Diseases, University Paris Descartes, 
Hospital Necker Enfants Malades, APHP, 75015 Paris, France; UMR1163, University 
Paris Descartes, Sorbonne Paris Cité, Institut IMAGINE, 24 Boulevard du 
Montparnasse, 75015 Paris, France.
(3)Institute of Human Genetics, Technische Universität München, 81675 Munich, 
Germany; Institute of Human Genetics, Helmholtz Zentrum München, 85764 
Neuherberg, Germany; Institute of Medical Genetics and Applied Genomics, 
University of Tübingen, 72076 Tübingen, Germany.
(4)Department of Pediatrics, Paracelsus Medical University Salzburg, 5020 
Salzburg, Austria.
(5)Department of Biochemistry, Hospital Bicêtre, APHP, 94270 Le Kremlin Bicêtre, 
France.
(6)Department of Neuropediatrics, Children's Hospital Klinikum Oldenburg, 
Oldenburg 26133, Germany.
(7)Reference Center of Inherited Metabolic Diseases, University Paris Descartes, 
Hospital Necker Enfants Malades, APHP, 75015 Paris, France.
(8)Neurology Unit, Limoges Hospital, 87042 Limoges, France.
(9)Neurophysiology Unit, Hospital Necker Enfants Malades, APHP, 75015 Paris, 
France; INSERM U1129, Paris, France; Paris Descartes University; CEA, Gif sur 
Yvette; Paris, France.
(10)UMR1163, University Paris Descartes, Sorbonne Paris Cité, Institut IMAGINE, 
24 Boulevard du Montparnasse, 75015 Paris, France.
(11)Genomic Core Facility, Imagine Institute, UMR1163, University Paris 
Descartes, 24 Boulevard du Montparnasse, 75015 Paris, France; Hospital Necker 
Enfants Malades, APHP, 75015 Paris, France.
(12)Paris Descartes Bioinformatic Platform, University Paris Descartes, Hospital 
Necker Enfants Malades, 75015 Paris, France.
(13)Reference Center of Inherited Metabolic Diseases, University Paris 
Descartes, Hospital Necker Enfants Malades, APHP, 75015 Paris, France; 
Neurophysiology Unit, Hospital Necker Enfants Malades, APHP, 75015 Paris, 
France; INSERM U1129, Paris, France; Paris Descartes University; CEA, Gif sur 
Yvette; Paris, France.
(14)Department of Pediatric Radiology, Hospital Necker Enfants Malades, AP-HP, 
University René Descartes, PRES Sorbonne Paris Cité, INSERM U1000, Institut 
Imagine 24 Boulevard du Montparnasse, 75015 Paris, France.
(15)Faculty of Medicine, Paris Descartes University, Paris 75015, France; Necker 
Enfants Malades Institute, INSERM U1151, Paris Descartes University, 75015 
Paris, France.
(16)Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, University 
Paris-Sud, Université Paris-Saclay, 91198 Gif-sur-Yvette Cedex, France.
(17)Department of General Pediatrics, Division of Pediatric Neurology and 
Inherited Metabolic Diseases, University Children's Hospital, 69120 Heidelberg, 
Germany.
(18)Radboud Center for Mitochondrial Medicine, Department of Pediatrics, Radboud 
UMC, Nijmegen, the Netherlands.
(19)Institute of Human Genetics, Technische Universität München, 81675 Munich, 
Germany; Institute of Human Genetics, Helmholtz Zentrum München, 85764 
Neuherberg, Germany.
(20)Department of Pediatrics, Paracelsus Medical University Salzburg, 5020 
Salzburg, Austria. Electronic address: h.mayr@salk.at.
(21)Reference Center of Inherited Metabolic Diseases, University Paris 
Descartes, Hospital Necker Enfants Malades, APHP, 75015 Paris, France; UMR1163, 
University Paris Descartes, Sorbonne Paris Cité, Institut IMAGINE, 24 Boulevard 
du Montparnasse, 75015 Paris, France. Electronic address: 
pascale.delonlay@aphp.fr.

Lipoate serves as a cofactor for the glycine cleavage system (GCS) and four 
2-oxoacid dehydrogenases functioning in energy metabolism (α-oxoglutarate 
dehydrogenase [α-KGDHc] and pyruvate dehydrogenase [PDHc]), or amino acid 
metabolism (branched-chain oxoacid dehydrogenase, 2-oxoadipate dehydrogenase). 
Mitochondrial lipoate synthesis involves three enzymatic steps catalyzed 
sequentially by lipoyl(octanoyl) transferase 2 (LIPT2), lipoic acid synthetase 
(LIAS), and lipoyltransferase 1 (LIPT1). Mutations in LIAS have been associated 
with nonketotic hyperglycinemia-like early-onset convulsions and encephalopathy 
combined with a defect in mitochondrial energy metabolism. LIPT1 deficiency 
spares GCS deficiency and has been associated with a biochemical signature of 
combined 2-oxoacid dehydrogenase deficiency leading to early death or Leigh-like 
encephalopathy. We report on the identification of biallelic LIPT2 mutations in 
three affected individuals from two families with severe neonatal 
encephalopathy. Brain MRI showed major cortical atrophy with white matter 
abnormalities and cysts. Plasma glycine was mildly increased. Affected 
individuals' fibroblasts showed reduced oxygen consumption rates, PDHc, α-KGDHc 
activities, leucine catabolic flux, and decreased protein lipoylation. A 
normalization of lipoylation was observed after expression of wild-type LIPT2, 
arguing for LIPT2 requirement in intramitochondrial lipoate synthesis. Lipoic 
acid supplementation did not improve clinical condition nor activities of PDHc, 
α-KGDHc, or leucine metabolism in fibroblasts and was ineffective in yeast 
deleted for the orthologous LIP2.

Copyright © 2017 American Society of Human Genetics. Published by Elsevier Inc. 
All rights reserved.

DOI: 10.1016/j.ajhg.2017.07.001
PMCID: PMC5544388
PMID: 28757203 [Indexed for MEDLINE]